Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0578320230460010004
Molecules and Cells
2023 Volume.46 No. 1 p.4 ~ p.9
RNA in Therapeutics: CRISPR in the Clinic
Carroll Dana

Abstract
The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances in these areas.
KEYWORD
base editing, Cas9, CRISPR, genome editing, prime editing, sickle cell disease
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)